Search

Author/Creator Boundy, Keith

1. Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin. Issue 5 (23rd January 2020)

Authors:
Bhagunde, Pratik; Colon‐Gonzalez, Francheska; Liu, Yang; Wu, Jin; Xu, Shiyao Sherrie; Garrett, Graigory; Jumes, Patricia; Lasseter, Kenneth; Marbury, Thomas; Rizk, Matthew L.; Lala, Mallika; Rhee, Elizabeth G.; Butterton, Joan R.; Boundy, Keith
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 5(2020)
Page Start:
944
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy Participants. Issue 4 (25th March 2020)

Authors:
Boundy, Keith; Liu, Yang; Bhagunde, Pratik; O'Reilly, Terry E.; Colon‐Gonzalez, Francheska; Friedman, Evan J.; Lala, Mallika; Rhee, Elizabeth G.; Rizk, Matthew L.
Journal:
Clinical pharmacology in drug development
Issue:
Volume 9:Issue 4(2020)
Page Start:
466
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗